Most can be managed with simple adjustments
Patients relax in a comfortable recliner or bed during the infusion, and most resume daily activities right after
Start your intake What Timeline to Expect: Clinical Evidence and Dose Progression Tirzepatide's dual GLP-1 and GIP receptor agonism typically produces appetite suppression within days, but weight loss becomes measurable around week 24 at therapeutic doses
450,000+ law firm and corporate customers, including 90%+ of Am Law 100 Corporate Performance & ESG Help customers manage risks, meet finance, risk and disclosure requirements, increase worker safety & productivity, and reduce environmental impact
Am I a good candidate for Mounjaro/Zepbound
The amylin component contributes to blood sugar control through glucagon suppression and delayed gastric emptying, both of which reduce postprandial glucose spikes